Scottish tech company Novosound develops world’s first ultrasound blood pressure monitor

Novosound now poised to revolutionise blood pressure monitoring in wearables.

Novosound, the pioneering Scottish tech company, has developed the world’s first ultrasonic blood pressure monitor. This breakthrough allows for the miniaturisation of blood pressure monitoring in wearable devices, including smartwatches and smart rings, achieving accuracy levels comparable to conventional electronic cuff devices.

Built on Novosound’s Slanj platform, the technology follows the company’s previous collaboration at the Texas Medical Centre in Houston and is now poised to revolutionise blood pressure monitoring in wearables. Unlike academic institutions that have focused primarily on laboratory-based development, Novosound has already demonstrated the system in real-world settings, including public spaces. The results, including accuracy data, were presented at the IEEE International Ultrasonics Symposium (IUS) in Taipei in September, further strengthening the credibility of the system.

Dave Hughes, CEO and Founder of Novosound, said: “Scotland has long been at the forefront of ultrasound innovation, and we are proud to continue this legacy. Monitoring blood pressure with ultrasound, and without the need for a cuff, marks a significant advancement in how we can address global health and wellness issues.”

Cardiovascular diseases continue to affect over half a billion people globally, with more than 20 million deaths in 2021, according to the World Heart Federation.

In addition to this milestone, Novosound recently completed a £2 million funding round, led by Par Equity with participation from Kelvin Capital, University of the West of Scotland, and Scottish Enterprise. This funding will accelerate the commercialisation of Novosound’s innovative ultrasound technology.

John McNicol, Director of Kelvin Capital said: ““Kelvin Capital is excited to further support Novosound as they continue to push the boundaries of ultrasonic technology.  Their groundbreaking innovations are driving significant advancements across industries, from healthcare to industrial sectors.  This follow-on investment underscores our confidence in the team, technology, and vision for the future.  We believe that Novosound is poised to achieve even greater milestones, and we are proud to support their journey towards global growth and success”

Professor James Miller, Principal & Vice-Chancellor of the University of the West of Scotland, commented: “This latest investment ensures that our first high-value spinout will continue its growth trajectory as it enters an exciting new phase with many opportunities on the horizon.”